Corient Private Wealth LP Acquires New Position in Danaher Corporation $DHR

Corient Private Wealth LP bought a new position in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 705,975 shares of the conglomerate’s stock, valued at approximately $134,475,000. Corient Private Wealth LP owned about 0.10% of Danaher as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Meeder Asset Management Inc. acquired a new stake in Danaher during the 2nd quarter worth approximately $44,000. MidFirst Bank purchased a new position in Danaher in the second quarter valued at about $46,000. Bell Investment Advisors Inc acquired a new stake in Danaher during the 2nd quarter valued at approximately $47,000. Fiduciary Financial Advisors purchased a new stake in Danaher during the 2nd quarter worth approximately $53,000. Finally, Solstein Capital LLC bought a new stake in shares of Danaher in the second quarter worth $58,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on DHR. Piper Sandler initiated coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective on the stock. Stifel Nicolaus cut their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Evercore reaffirmed an “outperform” rating and set a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. HSBC lowered their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Finally, Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Stock Down 0.0%

Shares of NYSE:DHR opened at $215.90 on Thursday. The company’s fifty day moving average is $197.93 and its two-hundred day moving average is $192.36. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The stock has a market capitalization of $151.77 billion, a price-to-earnings ratio of 38.35, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same period in the previous year, the business posted $0.77 EPS. The company’s quarterly revenue was up 5.5% on a year-over-year basis. Equities analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.